Format

Send to

Choose Destination
Per Med. 2015;12(4):339-347.

Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.

Author information

1
Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN.
2
Institute of Clinical and Translational Research, Vanderbilt University School of Medicine, Nashville, TN.
3
Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN ; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.

Abstract

AIM:

To describe the knowledge and attitudes of clinicians participating in a large pharmacogenomics implementation program.

MATERIALS & METHODS:

Semi-structured interviews with 15 physicians and nurse practitioners were conducted.

RESULTS:

Three categories of themes were identified: preparation and knowledge, pharmacogenomics usage in practice, and future management of genomic variants. Providers expressed an inability to keep up with the rapid pace of evidence generation and indicated strong support for clinical decision support to assist with genotype-tailored therapies. Concerns raised by clinicians included effectively communicating results, long-term responsibility for actionable results and hand-offs with providers outside the implementation program.

CONCLUSIONS:

Clinicians identified their own knowledge deficits, workflow integration, and longitudinal responsibility as challenges to successful usage of pharmacogenomics in clinical practice.

KEYWORDS:

attitudes; personalized medicine; pharmacogenomics; qualitative research; translational research

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center